ProCE Banner Activity

SALSA Post hoc Analysis: Proportion of Patients With Baseline Archived Resistance Attaining Stringent Efficacy Criteria After Switch to DTG/3TC

Slideset Download
Conference Coverage
Using stringent criteria of HIV-1 RNA <40 copies/mL and target not detected, proportions of patients with BL archived resistance mutations who responded were similar with DTG/3TC vs continued 3-drug ART at Week 48.

Released: February 16, 2022

Expiration: February 15, 2023

No longer available for credit.


Provided by

Provided by Clinical Care Options, LLC
ProCE Banner


Supported by educational grants from


Gilead Sciences, Inc.

Janssen Therapeutics Division of Janssen Products

Merck & Co., Inc.

ViiV Healthcare